Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $395.0000 (2.6%) ($390.0000 - $410.0000) on Thu. May. 5, 2011. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.19% (three month average) | RSI | 61 | Latest Price | $395.0000(2.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.9% a day on average for past five trading days. | Weekly Trend | CAPR advances 9.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(4%) EWP(3%) IWM(3%) XOP(3%) EWI(2%) | Factors Impacting CAPR price | CAPR will decline at least -3.095% in a week (0% probabilities). REMX(-1%) IGOV(-1%) EWY(-1%) XLU(0%) XLP(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.095% (StdDev 6.19%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $400(-1.25%) | 10 Day Moving Average | $383.84(2.91%) | 20 Day Moving Average | $367.35(7.53%) | To recent high | -10.2% | To recent low | 43.6% | Market Cap | $7.781b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |